GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Molecular Templates Inc (FRA:NZW) » Definitions » EBITDA Margin %

Molecular Templates (FRA:NZW) EBITDA Margin % : -3,701.70% (As of Jun. 2024)


View and export this data going back to 2007. Start your Free Trial

What is Molecular Templates EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Molecular Templates's EBITDA for the three months ended in Jun. 2024 was €-6.52 Mil. Molecular Templates's Revenue for the three months ended in Jun. 2024 was €0.18 Mil. Therefore, Molecular Templates's EBITDA margin for the quarter that ended in Jun. 2024 was -3,701.70%.


Molecular Templates EBITDA Margin % Historical Data

The historical data trend for Molecular Templates's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Molecular Templates EBITDA Margin % Chart

Molecular Templates Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -343.31 -635.05 -188.67 -407.84 2.21

Molecular Templates Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -115.69 -45.62 -41.00 15.79 -3,701.70

Competitive Comparison of Molecular Templates's EBITDA Margin %

For the Biotechnology subindustry, Molecular Templates's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Molecular Templates's EBITDA Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Molecular Templates's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Molecular Templates's EBITDA Margin % falls into.



Molecular Templates EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Molecular Templates's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=1.067/48.257
=2.21 %

Molecular Templates's EBITDA Margin % for the quarter that ended in Jun. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Jun. 2024 )/Revenue (Q: Jun. 2024 )
=-6.515/0.176
=-3,701.70 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Molecular Templates  (FRA:NZW) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Molecular Templates EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Molecular Templates's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Molecular Templates Business Description

Traded in Other Exchanges
Address
9301 Amberglen Boulevard, Suite 100, Austin, TX, USA, 78729
Molecular Templates Inc is a clinical-stage biopharmaceutical company focused on developing therapeutic agents that selectively target tumor cells for the treatment of individuals living with cancer.

Molecular Templates Headlines

No Headlines